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BACKGROUND & AIMS: Chronic liver diseases are highly prevalent and require
an accurate evaluation of liver fibrosis to determine patient management. Over the
last decade, great effort has been made to develop non-invasive liver fibrosis tests.
The ensuing increase of literature is, however, impaired by extensive heterogeneity
in the quality of published reports. The Standards for Reporting of Diagnostic
Accuracy Studies (STARD), first published in 2003, were developed to improve the
quality of research reports on diagnostic studies. We aimed to evaluate STARD
statements in the setting of diagnostic studies on non-invasive liver fibrosis tests,
and to propose an extended version developed specifically for those studies.
METHODS: Eight French experts evaluated STARD statement adequacy in 10
studies on non-invasive liver fibrosis tests and then developed an extended version
with a glossary. The new checklist and glossary were independently evaluated by
seven international experts.
RESULTS: Fourteen of the 25 STARD items were considered only partially
adequate for the evaluation of diagnostic studies on non-invasive liver fibrosis
tests. Inter-expert agreement was at least very good for 8 STARD items (32%),
moderate for 9 (36%), and poor or very poor for 8 (32%). The experts' proposals
were developed into the new Liver-FibroSTARD standards including a checklist
with 62 items/sub-items and a corresponding comprehensive glossary. New
proposals were inserted in the 25 STARD items as a complementary module.
Independent evaluation of the Liver-FibroSTARD checklist showed at least very
good inter-expert agreement for 39 items/sub-items (63%), moderate agreement for
11 (18%), and poor or very poor agreement for only 12 (19%).
CONCLUSIONS: As a supplement of the STARD statements, the Liver-
FibroSTARD checklist and its glossary are new tools specifically designed for the
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